Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New AdvaMed Exec Donald May Weighs In On Reimbursement Priorities

This article was originally published in The Gray Sheet

Executive Summary

In an interview with “The Gray Sheet,” Donald May, the new executive vice president of payment and health care delivery policy at AdvaMed, discusses priorities in his new role with the association.

You may also be interested in...



People Briefs: Cook Medical Names President; Smith & Nephew Gains Chairman-Elect

Cook Medical appoints a new president. Smith & Nephew names Roberto Quarta chairman-elect. Mela Sciences appoints Rose Crane president and CEO.

CMS Advisors And Industry Groups Press Agency To Delay Outpatient System Changes

CMS faces pressure from one of its advisory panels and the device industry to delay implementation of proposals in its draft 2014 hospital outpatient payment rule related to the development of comprehensive ambulatory payment classifications, implementation of new cost centers for CT and MRI, and seven new packaging policies.

Industry Pushes CMS For Details On Centralized Coverage Review Of IDE Trials

Whether they support centralized review or not, device manufacturers want CMS to provide more detail on how the process would work – including timelines, the extent of manufacturer interactions with agency staff, and how appeals would be handled.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032613

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel